Inovio Pharmaceuticals (NASDAQ:INO) Rating Lowered to “Sell” at StockNews.com
Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Friday. Other research analysts have also issued reports about the company. JMP Securities reissued a “market outperform” rating and set a $18.00 price target on shares of […]
